8-KThe WireRed Alert
Executive Change · Reg FD Disclosure
Filed Jul 7, 2025 · 11mo ago · Accession 0001171843-25-004324
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- 8-K
- Filing date
- Jul 7, 2025
- Report date
- Jul 7, 2025
- Document
- f8k_070725.htm
- Size
- 225 KB